Basic Information
Basic information for SNHG17-231-38aa
Peptide Name SNHG17-231-38aa
Genome Position chr20:38421107-38421220[-]
Species Human
Peptide Sequence MLSVAVAEEEPPEICVGKVSSPGEPSSSLERWCVHSVL
Peptide Length 38
Unique No (SNHG17-202-38aa,SNHG17-224-38aa,SNHG17-230-38aa,SNHG17-233-38aa,SNHG17-258-38aa,SNHG17-267-38aa,SNHG17-272-38aa,SNHG17-274-38aa,SNHG17-278-38aa,SNHG17-280-38aa,SNHG17-284-38aa)
Grand Average of Hydropathicity 0.1395
Relative Molecular Mass 4706.13
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000658051;SNHG17-231
Transcript Length 1979
Coding Ability 0.3931
DNA Sequence Corresponding to Peptide ATGCTTTCAGTGGCTGTTGCAGAGGAAGAGCCTCCGGAAATCTGCGTGGGTAAAGTGAGCTCCCCGGGGGAACCGTCCTCCTCCCTTGAGCGCTGGTGTGTCCATAGTGTGCTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :